why choose us

First received: October 14, 2022

Clinical Trial: EO4010 in Previously Treated Metastatic Colorectal Carcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colorectal Cancer Metastatic

Study Type: INTERVENTIONAL


Official Title: A Global Multicenter Phase 1/2 Trial of EO4010, a Novel Microbial Derived Peptide Therapeutic Vaccine, in Combination With Nivolumab, for Treatment of Patients With Previously Treated Metastatic

Brief Summary: Open-label multicenter study

Read more